Entero Healthcare Solutions Limited (NSE:ENTERO)
1,103.70
-8.20 (-0.74%)
Oct 29, 2025, 3:29 PM IST
NSE:ENTERO Revenue
Entero Healthcare Solutions had revenue of 14.04B INR in the quarter ending June 30, 2025, with 27.96% growth. This brings the company's revenue in the last twelve months to 54.03B, up 31.13% year-over-year. In the fiscal year ending March 31, 2025, Entero Healthcare Solutions had annual revenue of 50.96B with 29.92% growth.
Revenue (ttm)
54.03B
Revenue Growth
+31.13%
P/S Ratio
0.89
Revenue / Employee
13.14M
Employees
4,111
Market Cap
48.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50.96B | 11.73B | 29.92% |
| Mar 31, 2024 | 39.22B | 6.22B | 18.85% |
| Mar 31, 2023 | 33.00B | 7.78B | 30.85% |
| Mar 31, 2022 | 25.22B | 7.49B | 42.24% |
| Mar 31, 2021 | 17.73B | 4.23B | 31.38% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |